ArticleFrontiers in surgery2026
An interpretable nomogram with SHAP analysis predicts thrombotic failure of forearm arteriovenous fistulas.
Article in Frontiers in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: End-stage renal disease is an increasing global health problem. Arteriovenous fistula (AVF) thrombosis is a major cause of access failure in maintenance hemodialysis (MHD) patients. An interpretable nomogram, integrated with SHapley Additive exPlanations (SHAP) analysis is developed and validated for predicting thrombotic failure of forearm AVFs in MHD patients. Methods: A single-center retrospective cohort study enrolled 302 MHD patients with dysfunctional forearm AVFs undergoing percutaneous transluminal angioplasty. Patients were randomly allocated to training (70%) and validation (30%) sets. Univariable and multivariable logistic regression identified independent predictors for AVF thrombosis. A nomogram was constructed and its performance evaluated by the area under the receiver operating characteristic curve, calibration, and decision curve analysis. SHAP analysis was applied to quantify feature importance and directionality in the validation set. Results: The final model identified hypertension history, frequent intradialytic hypotension, body mass index, total cholesterol, C-reactive protein, and intact parathyroid hormone as independent predictors. The nomogram demonstrated good discrimination, with AUCs of 0.80 (95% CI: 0.73-0.86) in the training set and 0.71 (95% CI: 0.59-0.83) in the validation set, along with satisfactory calibration and clinical utility. SHAP analysis revealed red cell distribution width-standard deviation as the most influential predictor for individual risk, highlighting a distinction between statistical significance and predictive contribution. Conclusion: This study presents an interpretable nomogram with robust performance for predicting AVF thrombosis. The integration of SHAP analysis enhances model transparency and clinical trust, providing a valuable tool for personalized risk assessment and potential targeting of preventive strategies in MHD patients. Further external validation is warranted.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.